Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
647 studies found for:    osteoporosis AND (woman OR women OR female)
Show Display Options
Download search resultsDownload the search results for:
osteoporosis AND (woman OR women OR female) (647 records)
Download Content:
Zip file readers with free trial periods: WinZip or PKZip
Rank Status Study
1 Recruiting Evaluation of an Osteoporosis Prevention Strategy in Women With Osteoporotic Fracture of the Upper Limb
Condition: Osteoporosis With Current Fragility Fracture
Intervention: Behavioral: Osteoporosis prevention program
2 Completed TOP: Trial of the Effect of Recombinant Human Parathyroid Hormone (ALX1-11) on Fracture Incidence in Women With Postmenopausal Osteoporosis
Condition: Osteoporosis
Intervention: Drug: ALX1-11
3 Not yet recruiting Characteristics and Management of Postmenopausal Women With Osteoporosis Treated With Prolia® in France
Condition: Post Menopausal Osteoporosis
Intervention: Drug: AMG 162 - Prolia
4 Completed Study of Teriparatide in the Treatment of Postmenopausal Women With Osteoporosis
Condition: Osteoporosis, Post-Menopausal
Intervention: Drug: teriparatide
5 Completed Comparison of Raloxifene Hydrochloride and Placebo in the Treatment of Postmenopausal Women With Osteoporosis
Condition: Osteoporosis, Postmenopausal
Interventions: Drug: Raloxifene HCL;   Drug: Placebo
6 Completed Optimal Management of Women With Wrist Fractures
Conditions: Osteoporosis;   Osteopenia
Intervention: Procedure: Educational Material and Reminder
7 Completed The Effect of a Short Educational Program on Young Women's Knowledge and Beliefs About Osteoporosis
Condition: Osteoporosis
Intervention: Behavioral: Education
8 Completed
Has Results
Study Evaluating Bazedoxifene Acetate In Osteoporosis In Postmenopausal Women
Condition: Osteoporosis
Interventions: Drug: Bazedoxifene Acetate;   Other: Placebo
9 Recruiting Forteo Trial on Idiopathic Osteoporosis in Premenopausal Women
Condition: Adult Idiopathic Generalized Osteoporosis
Interventions: Drug: Teriparatide;   Drug: Saline Placebo
10 Completed A Study of the Treatment of Postmenopausal Women With Osteoporosis
Condition: Osteoporosis, Post-Menopausal
Interventions: Drug: teriparatide 20 micrograms/day subcutaneous;   Drug: salmon calcitonin 100 IU/day subcutaneous
11 Completed Comparison Medications in the Treatment of Postmenopausal Women With Osteoporosis
Condition: Osteoporosis, Postmenopausal
Interventions: Drug: teriparatide 20 micrograms/day subcutaneous;   Drug: salmon calcitonin 100 IU/day subcutaneous
12 Active, not recruiting Oklahoma Native American Women's Osteoporosis Screening Study
Condition: Osteoporosis
Intervention:
13 Completed Effects of Teriparatide in the Treatment of Postmenopausal Women With Osteoporosis
Condition: Osteoporosis, Postmenopausal
Interventions: Drug: teriparatide;   Drug: Placebo;   Drug: Calcium Supplement;   Drug: Vitamin D Supplement
14 Not yet recruiting Compliance and Persistence With Osteoporosis Treatment and Attitude Towards Future Therapy Among Post-menopausal Israeli Women During Drug Treatment or Drug Holiday
Condition: Osteoporosis
Intervention: Other: Questionnaires about compliance and persistence with bisphosphonates treatment
15 Active, not recruiting Forteo for the Treatment of Unexplained Osteoporosis in Premenopausal Women
Conditions: Premenopause;   Low Bone Density;   Fracture;   Osteoporosis
Intervention: Drug: Teriparatide (PTH 1-34)
16 Active, not recruiting A Double-blind Study to Assess the Efficacy and Safety of Denosumab Produced by Two Different Processes in Postmenopausal Women With Osteoporosis
Condition: Postmenopausal Osteoporosis
Interventions: Drug: Denosumab (CP2);   Drug: Denosumab (CP4)
17 Recruiting Effects of Teriparatide (PTH) on Bone in Men and Women With Osteoporosis
Condition: Osteoporosis
Intervention: Drug: Teriparatide
18 Unknown  Recognizing Osteoporosis and Its Consequences in Quebec (ROCQ) Programme
Condition: Osteoporosis
Interventions: Behavioral: Control Group;   Behavioral: Written documentation on osteoporosis group;   Behavioral: Written documentation on osteoporosis and video group
19 Recruiting Study to Determine the Efficacy and Safety of Romosozumab in the Treatment of Postmenopausal Women With Osteoporosis
Condition: Postmenopausal Women With Osteoporosis
Interventions: Drug: Romosozumab;   Drug: Alendronate
20 Completed PTH Comparison in Post Menopausal Women
Condition: Osteoporosis, Post-Menopausal
Interventions: Drug: teriparatide 20 micrograms/day subcutaneous;   Drug: calcitonin 100 IU/day subcutaneous

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years